"Renal cell carcinoma, not otherwise specified” is not a sufficient diagnostic classification

Virchows Archiv · Published 2026-08-05 · DOI 10.1007/s00428-026-04664-2

Free full text

Authors (4)

Nazif Alperen Yildirim, Busra Yaprak Bayrak, Liang Cheng, Mahmut Akgul

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yildirim, N., Bayrak, B., Cheng, L., et al. (2026). "Renal cell carcinoma, not otherwise specified” is not a sufficient diagnostic classification. Virchows Archiv. https://doi.org/10.1007/s00428-026-04664-2

Related articles

• Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors · Human Pathology · 2026 · Cites or is cited by this article
• Clinicopathological analysis of 21 cases of “Synchronous” endocervical and ovarian adenocarcinomas · Virchows Archiv · 2026 · Same journal
• Combined inverted follicular keratosis and adnexal tumors: a series of 12 cases · Virchows Archiv · 2026 · Same journal
• Clinicopathological features and risk stratification for lymph node metastasis in early-stage colorectal cancer (from intramucosal carcinoma to SM2): a large-scale retrospective study based on a Chinese population · Virchows Archiv · 2026 · Same journal
• High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images · Virchows Archiv · 2026 · Same journal
• ASPSCR1::TFE3-rearranged renal cell carcinomas: clinicopathologic, molecular, and survival analysis of 30 cases · Virchows Archiv · 2026 · Same journal
• MYD88L265P mutation is a highly specific marker for the nonGCB/ABC DLBCL molecular subtype · Virchows Archiv · 2026 · Same journal
• Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma · Virchows Archiv · 2026 · Same journal
• GPR143, a novel immunohistochemical marker for renal tumors with FLCN/TSC/MTOR-TFE alterations · Virchows Archiv · 2026 · Same journal
• Sarcomatous transformation of an astrocytoma IDH-mutant following radiotherapy · Virchows Archiv · 2026 · Same journal